Table 3 of
Zou, Mol Vis 2014; 20:977-987. Table 3 of
Zou, Mol Vis 2014; 20:977-987.
Table 3. Biometic changes induced by fdm in the presence or absenceof atropine treatment.
| Groups | Eye | Refraction Diopter (D) | Anterior Chamber Depth (mm) | Lens Thickness (mm) | Axial Length (mm) |
|---|---|---|---|---|---|
| Control | R(normal) | +2.10±0.73 | 1.28±0.02 | 3.26±0.09 | 8.01±0.04 |
| L(normal) | +2.13±0.90 | 1.29±0.01 | 3.27±0.08 | 8.02±0.06 | |
| FDM | R(FD) | −1.28±0.09* | 1.29±0.01 | 3.28±0.09 | 8.27±0.08* |
| L(normal) | +2.15±0.12 | 1.28±0.02 | 3.26±0.07 | 7.99±0.09 | |
| FDM + | R(FD) | −1.37±0.08 | 1.32±0.03 | 3.26±0.09 | 8.30±0.14 |
| Saline | L(normal) | +2.15±0.13 | 1.33±0.04 | 3.21±0.10 | 8.03±0.12 |
| FDM + | R(FD) | +1.32±0.19* | 1.30±0.01 | 3.28±0.09 | 8.14±0.06* |
| Atropine | L(normal) | +2.14±0.27 | 1.33±0.03 | 3.35±0.11 | 8.04±0.09 |